Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sridhar Mani

Showing results (91-100 of 170) with videos related to

Pageof 17
Sort By:
The British Journal of Nutrition|March 20, 2013
Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-κB signallingWei Dou, Jingjing Zhang, Aning Sun, et al.
Cancer Chemotherapy and Pharmacology|May 17, 2005
Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancerApurva A Desai, Hedy L Kindler, David Taber, et al.
The Annals of Pharmacotherapy|October 21, 2010
Induction of CYP3A4 by vinblastine: Role of the nuclear receptor NR1I2Nicola F Smith, Sridhar Mani, Erin G Schuetz, et al.
The Journal of Biological Chemistry|March 26, 2013
Novel yeast-based strategy unveils antagonist binding regions on the nuclear xenobiotic receptor PXRHao Li, Matthew R Redinbo, Madhukumar Venkatesh, et al.
JAMA Network Open|July 11, 2024
Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers in Phase 1 Trials: A Meta-AnalysisSanjay Goel, Abdissa Negassa, Mohammad H Ghalib, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2005
Clinical and pharmacokinetic study evaluating the effect of food on the disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in patients with solid tumorsWilliam C Zamboni, Sanjay Goel, Tahir Iqbal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancerSridhar Mani, Charles M Rudin, Katie Kunkel, et al.
Frontiers in Physiology|February 4, 2021
Acacetin Ameliorates Experimental Colitis in Mice via Inhibiting Macrophage Inflammatory Response and Regulating the Composition of Gut MicrobiotaJunyu Ren, Bei Yue, Hao Wang, et al.
Gynecologic Oncology|July 24, 2013
Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: a single institution experience from 1999 to 2010June Y Hou, Santiago Aparo, Mohammad Ghalib, et al.
Investigational New Drugs|May 10, 2006
A phase I safety and dose escalation trial of docetaxel combined with GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patients with advanced solid cancersSanjay Goel, Kavita Desai, Manuel Macapinlac, et al.
Pageof 17

Showing results (91-100 of 170) with videos related to

Sort By:
Pageof 17
The British Journal of Nutrition|March 20, 2013
Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-κB signallingWei Dou, Jingjing Zhang, Aning Sun, et al.
Cancer Chemotherapy and Pharmacology|May 17, 2005
Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancerApurva A Desai, Hedy L Kindler, David Taber, et al.
The Annals of Pharmacotherapy|October 21, 2010
Induction of CYP3A4 by vinblastine: Role of the nuclear receptor NR1I2Nicola F Smith, Sridhar Mani, Erin G Schuetz, et al.
The Journal of Biological Chemistry|March 26, 2013
Novel yeast-based strategy unveils antagonist binding regions on the nuclear xenobiotic receptor PXRHao Li, Matthew R Redinbo, Madhukumar Venkatesh, et al.
JAMA Network Open|July 11, 2024
Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers in Phase 1 Trials: A Meta-AnalysisSanjay Goel, Abdissa Negassa, Mohammad H Ghalib, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2005
Clinical and pharmacokinetic study evaluating the effect of food on the disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in patients with solid tumorsWilliam C Zamboni, Sanjay Goel, Tahir Iqbal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancerSridhar Mani, Charles M Rudin, Katie Kunkel, et al.
Frontiers in Physiology|February 4, 2021
Acacetin Ameliorates Experimental Colitis in Mice via Inhibiting Macrophage Inflammatory Response and Regulating the Composition of Gut MicrobiotaJunyu Ren, Bei Yue, Hao Wang, et al.
Gynecologic Oncology|July 24, 2013
Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: a single institution experience from 1999 to 2010June Y Hou, Santiago Aparo, Mohammad Ghalib, et al.
Investigational New Drugs|May 10, 2006
A phase I safety and dose escalation trial of docetaxel combined with GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patients with advanced solid cancersSanjay Goel, Kavita Desai, Manuel Macapinlac, et al.
Pageof 17